drugset / Trial / NCT04355845

A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.

NCT04355845

Phase 1 Completed 10 enrolled Pfizer
RandomizedSequentialOpen-labelBasic science

Summary

Study to evaluate the effect of pf-06651600 on pharmacokinetics of single dose sumatriptan.

Timeline

Start
2020-06-15
Primary completion
2020-08-10
Completion
2020-08-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ritlecitinib Small molecule 400 mg Oral
Subject Sumatriptan Unknown 25 mg Oral

Indications

No indication recorded.